These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 11904965)

  • 61. Monoclonal antibodies in neuro-oncology.
    Stavrou D
    Neurosurg Rev; 1990; 13(1):7-18. PubMed ID: 2181345
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cellular immunity and immunotherapy of brain tumors.
    Prins RM; Liau LM
    Front Biosci; 2004 Sep; 9():3124-36. PubMed ID: 15353342
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The effectiveness of interferon-beta against glioma cells and its augmentation of growth inhibitory effect by transfection of its gene].
    Wakabayashi T; Mizuno M; Yoshida J
    Hum Cell; 1995 Sep; 8(3):95-8. PubMed ID: 8652452
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The meaning of the anti-cancer antibody CLN-IgG (Pritumumab) generated by human × human hybridoma technology against the cyto-skeletal protein, vimentin, in the course of the treatment of malignancy.
    Hugwil AV
    Med Hypotheses; 2013 Sep; 81(3):489-95. PubMed ID: 23856243
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunotherapy of malignant gliomas.
    Maleci A
    J Neurosurg Sci; 1989; 33(1):77-82. PubMed ID: 2674361
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intraperitoneal immunotherapy for metastatic ovarian carcinoma: Resistance of intratumoral collagen to antibody penetration.
    Choi J; Credit K; Henderson K; Deverkadra R; He Z; Wiig H; Vanpelt H; Flessner MF
    Clin Cancer Res; 2006 Mar; 12(6):1906-12. PubMed ID: 16551876
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Trial of targeting therapy against malignant glioma using monoclonal antibody.
    Takahashi H; Teramoto A
    J Nippon Med Sch; 2004 Feb; 71(1):2-3. PubMed ID: 15129587
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma.
    Yang L; Ng KY; Lillehei KO
    Cancer Control; 2003; 10(2):138-47. PubMed ID: 12712008
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Brain tumor immunotherapy: Illusion or hope?].
    Migliorini D; Dutoit V; Walker PR; Dietrich PY
    Bull Cancer; 2017 May; 104(5):476-484. PubMed ID: 28318492
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Novel immunotherapeutic approach].
    Kikuchi T
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):453-7. PubMed ID: 15853209
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines.
    Bernardi RJ; Lowery AR; Thompson PA; Blaney SM; West JL
    J Neurooncol; 2008 Jan; 86(2):165-72. PubMed ID: 17805488
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Emerging monoclonal antibody therapies for malignant gliomas.
    Gerber DE; Laterra J
    Expert Opin Investig Drugs; 2007 Apr; 16(4):477-94. PubMed ID: 17371196
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunotherapy of brain tumors.
    Sawamura Y; De Tribolet N
    J Neurosurg Sci; 1990; 34(3-4):265-78. PubMed ID: 2098505
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Monoclonal antibody therapy of human gliomas: current status and future approaches.
    Wikstrand CJ; Cokgor I; Sampson JH; Bigner DD
    Cancer Metastasis Rev; 1999; 18(4):451-64. PubMed ID: 10855788
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Monoclonal antibody therapy for malignant glioma.
    Chen KS; Mitchell DA
    Adv Exp Med Biol; 2012; 746():121-41. PubMed ID: 22639164
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunobiology of human gliomas.
    Bullard DE; Gillespie GY; Mahaley MS; Bigner DD
    Semin Oncol; 1986 Mar; 13(1):94-109. PubMed ID: 2420011
    [No Abstract]   [Full Text] [Related]  

  • 77. Localisation of malignant glioma by a radiolabelled human monoclonal antibody.
    Phillips J; Alderson T; Sikora K; Watson J
    J Neurol Neurosurg Psychiatry; 1983 May; 46(5):388-92. PubMed ID: 6101173
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunotherapeutic strategies for malignant glioma.
    Fenstermaker RA; Ciesielski MJ
    Cancer Control; 2004; 11(3):181-91. PubMed ID: 15153842
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Recent advances in experimental molecular therapeutics for malignant gliomas.
    Prasad G; Wang H; Hill DL; Zhang R
    Curr Med Chem Anticancer Agents; 2004 Jul; 4(4):347-61. PubMed ID: 15281907
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase.
    Kalofonos HP; Pawlikowska TR; Hemingway A; Courtenay-Luck N; Dhokia B; Snook D; Sivolapenko GB; Hooker GR; McKenzie CG; Lavender PJ
    J Nucl Med; 1989 Oct; 30(10):1636-45. PubMed ID: 2795204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.